Can a special PET scan see bladder cancer more clearly?
NCT ID NCT07750470
First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time
Summary
This study tests whether a specialized PET/CT scan using a radioactive tracer can more accurately determine the extent of muscle-invasive bladder cancer compared to standard CT scans. It will also explore whether changes seen on a follow-up scan after two cycles of chemotherapy can predict how well the tumor responds to treatment. The study enrolls 60 adults with newly diagnosed, high-grade muscle-invasive bladder cancer who are eligible for neoadjuvant chemotherapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 18F-FDG PET/CT imaging
- What this could lead to
- If successful, this imaging approach could improve how bladder cancer is staged and help predict whether chemotherapy is working, potentially guiding more personalized treatment decisions.
- What could go wrong
- This is a relatively small, single-center study. The imaging technique may not prove more accurate than current methods, and results may not apply to broader populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCLE-INVASIVE BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Azienda Ospedaliero-Universitaria di Ferrara
RECRUITINGFerrara, 44124, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Pre-Surgery chemotherapy outsmart aggressive bladder cancer?
- Bladder cancer: a new combo aims to avoid radical surgery
- Bladder cancer surgery: what happens after the bladder is removed?
- Lab-Grown tumor clusters guide tailored bladder cancer therapy
- Experimental immunotherapy targets tough urinary cancers
- Could an arthritis drug boost bladder cancer chemo?